Leticia Oliveira‐Ferrer
0000-0002-9075-0280
Publication & Citation Trends
Publications
123 total
Pre-operative circulating tumour cells as a liquid biopsy marker to predict worse surgery outcome in patients with high-grade serous ovarian cancer
Cited by 0
Semantic Scholar
Pre-operative circulating tumor cells predict worse treatment outcome in patients with high-grade serous ovarian cancer
Cited by 0
Semantic Scholar
Stromal PDGFR-beta expression is a prognostic factor in high-grade serous ovarian cancer patients but is it also predictive for response to antiangiogenic treatment?
Cited by 1
Semantic Scholar
Abstract P1-02-26: Biomarkers in metastatic breast cancer with brain metastases – a subanalysis of matched tumor samples of the BMBC registry
Cited by 0
Semantic Scholar
L-arginine dependence of breast cancer – molecular subtypes matter. OA
Cited by 4
Semantic Scholar
Transcriptome signature for the identification of bevacizumab responders in ovarian cancer
Cited by 2
Semantic Scholar
Epidermal growth factor receptor specific immunotherapy for SHH medulloblastoma tested in an in vitro blood-brain barrier-model.
Cited by 0
Semantic Scholar
Ovarian cancer cells regulate their mitochondrial content and high mitochondrial content is associated with a poor prognosis OA
Cited by 6
Semantic Scholar
Research Topics
Ovarian cancer diagnosis and treatment
(17)
Glycosylation and Glycoproteins Research
(17)
Galectins and Cancer Biology
(15)
Angiogenesis and VEGF in Cancer
(14)
Cell Adhesion Molecules Research
(14)
Affiliations
Universität Hamburg
University Medical Center
University Medical Center Hamburg-Eppendorf
Essen University Hospital
University Cancer Center Hamburg